surmount-1 tirzepatide 15 mg weight loss percent Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Results were over 72 weeks.

Patients at InCare Riverview report feeling satisfied with smaller portions and experiencing fewer sugar cravings

at 25 min, 80% A and 20% B

Our team at Slimming Solutions Med Spa is committed to helping you achieve and maintain your weight loss goals.

Abdominal aorta anastomosis in rats and stable gastric pentadecapeptide BPC 157, prophylaxis and therapy

The risk of bacterial contamination increases with every day past the recommended use period

Our dedicated shipping network ensures completely private, discrete handling with thick, unbranded thermal wrap to secure maximum customs clearance across global destinations